Praxis Precision Medicines Inc
PRAX - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$9.17B
Close$
$15.87
95.2% downside
Current Fair Value
95.2% downsideOvervalued by 95.2% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $9.17 Billion |
|---|---|
| Enterprise Value | $8.81 Billion |
| Earnings per Share | $-13.48 |
| Beta | 2.84 |
| Outstanding Shares | 29,178,396 |
Return
| Return on Equity | -28.54% |
|---|---|
| Return on Assets | -27.39% |
| Return on Invested Capital | -30.59% |
Valuation & Multiples
| P/E Ratio | -25.6 |
|---|---|
| PEG | -93.22 |
| Price to Sales | - |
| Price to Book Ratio | 7.63 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -22.87 |
| Enterprise Value to Net Income | -25 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 11, 2026
EPS Estimate
-$3.93
Consensus analyst estimateRevenue Estimate
$130,769
Consensus analyst estimateNext Earnings Call
Expected Date
February 18, 2027
EPS Estimate
-$4.08
Consensus analyst estimateRevenue Estimate
$376,929
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.09, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0937▼ 501.29% |
|---|---|
| Total Calls | 112,100▼ 32.10% |
| Total Puts | 10,500▼ 98.75% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 6.82%▼ 109.73% |
|---|---|
| Total Invested | $520.01M▼ 95.43% |
| Investors Holding | 116▼ 216.00% |
About Praxis Precision Medicines Inc
2,020 employees
Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders (CNS) characterized by neuronal imbalance. Praxis is applying in...